The government is exploring all possibilities to attract Japanese investment in India’s medical devices sector, a move which is likely to reduce the country’s dependence on US manufacturers.
Price curbs imposed on medical devices have irked US companies and become a key trade issue between Washington and New Delhi. Even as the US is sparring with India over this, the focus is now on fast-tracking investments from other countries, especially Japan, said people who are part of the discussions in the government.
PD Vaghela, the secretary at the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, held a high-level meeting with industry executives and government officials to discuss the current status of investments in medical devices, how to maximise Japanese investments and the regulatory issues. Representatives of Japanese companies like Omron Healthcare, Teremo Corp, Shimadzu Corp, Sysmex Corp, Horiba India, Hitachi India, Toshiba, Cura Healthcare and the Japan Federation of Medical Devices Association, and the first secretary at the Embassy of Japan in India attended the November 8 meeting.
Officials from the Ministry of Health, Department of Promotion of Industry and Internal Trade, Drug Controller General of India, and representatives from the CII, Ficci, Andhra Pradesh Medtech Zone and the Association of Indian Medical Device Industry (AiMed) were also present.
“Top government and industry representatives from Japanese companies and India deliberated various ways of strengthening the partnership between both countries,” said a person.
While Japanese brands have been household names in India for cameras, TVs and automobiles, the US remains the largest exporter of medical devices to India, followed by Germany, China, Singapore and the Netherlands.
The government is now looking at enhanced cooperation from Japanese investors to strengthen the domestic capacity of medical devices.
“Economic relations between India and Japan have vast potential for growth, given the similarities that exist between the two countries. Vision 2025 outlined by both countries aims to strengthen Indo-Japan relations by synergising business partnerships, facilitating investments and creating an empowering environment in India for Japanese investments. The meeting was held in view of that,” said a senior government official.
India’s medical device market is projected to grow to $50 billion by 2025 from $10 billion now. It is the fourth largest in Asia, after Japan, China and South Korea. Currently, India has 750-800 medical device manufacturers, with an average investment of Rs 170-200 million and an average turnover of Rs 450-500 million. While India allows 100% foreign direct investment in medical devices on the automatic route, investors have been wary due to the current regulatory environment.
India’s decision to slash prices of coronary stents by 85% in 2017 and then capping the prices of knee implants affected US exports, US trade representative had said in 2018.